| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 639,456 shares
@ $7.35, valued at
$4.7M
Granted 1,360,544 shares
@ $7.35, valued at
$10M
|
|
| 01/04/2022 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/23/2021 |
3
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 3 on Cue Health Inc. |
| 09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
3
| Decheng Capital Global Life Sciences Fund IV, L.P. (10% Owner) has filed a Form 3 on Equillium, Inc. |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2019 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 3,165,735 shares
@ $5.37, valued at
$17M
Granted 1,234,636 options to buy
@ $12.74, valued at
$15.7M
Granted 7,650 options to buy
@ $5.7008, valued at
$43.6k
|
|
| 01/23/2019 |
3
| Cui Xiangmin (10% Owner) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
| 06/22/2018 |
4
| Cui Xiangmin (Director) has filed a Form 4 on ARMO BioSciences, Inc.|
Txns:
| Unknown transaction of 1,214,700 shares
@ $50, valued at
$60.7M
Disposed/sold 18,000 options to buy
@ $39.97, valued at
$719.5k
|
|
| 03/28/2018 |
4
| Cui Xiangmin (Director) has filed a Form 4 on ARMO BioSciences, Inc.|
Txns:
| Granted 18,000 options to buy
@ $39.97, valued at
$719.5k
|
|
| 01/30/2018 |
4
| Cui Xiangmin (Director) has filed a Form 4 on ARMO BioSciences, Inc.|
Txns:
| Converted 1,214,700 shares
@ $0
Converted 1,214,700 convertible preferred
@ $0 |
|
| 01/25/2018 |
3
| Cui Xiangmin (Director) has filed a Form 3 on ARMO BioSciences, Inc. |
| 01/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/13/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/26/2010 |
3
| Cui Xiangmin (Director) has filed a Form 3 on China Biologic Products, Inc. |